Posts

Aldeyra’s allergic conjunctivitis treatment shows posit...

Aldeyra Therapeutics has just shared results for its phase 3 trial, the INVIGORA...

Skyrizi’s Breakthrough: Promising Results in Ulcerative...

AbbVie’s Skyrizi has posted another victory in a maintenance trial after complet...

Bio-Thera and Biomm enter licensing deal for ustekinuma...

BAT2206 received approval as a monotherapy or along with methotrexate to treat a...

Coherus BioSciences to acquire Surface Oncology for $65m

The deal will add Surface Oncology’s clinical stage assets, SRF388 and SFR114, t...

Cholesgen and AstraZeneca to advance research in hyperc...

The partnership will focus on selected targets from Cholesgen's early stage port...

Rosemont expands liquid medicine portfolio with Lucis a...

Rosemont is targeting the single-use sachet market, shaping its decision to acqu...

FDA extends review of GSK’s myelofibrosis drug

The FDA extends the review period for GSK’s Sierra Oncology myelofibrosis drug m...

China approves Medivir’s patent application for Fostrox

Medivir has already received patents for Fostrox in the EU, Japan, the US and a ...

Laurus Labs and IIT Kanpur partner for new gene therapy...

Laurus Labs will establish a GMP facility at IIT Kanpur’s Techno Park facility.

Overcoming regulatory issues with investigational medic...

For clinical trials operating across different counties, challenges with regulat...

STAT+: A chatbot that’s cautious about GPT, AI pronounc...

In the latest edition of STAT's Health Tech newsletter: a chatbot that's cautiou...

Mersana Hit With Another FDA Hold Linked to Patient Fat...

An additional FDA hold has been placed on Mersana Therapeutics in connection wit...

FDA approves Biostar’s Phase II/III plans with utidelon...

The company hopes to work with other partners to bring Utidelone to market.

Abu Dhabi DoH signs new deal to accelerate development ...

The deal will see expansion of research into genomic medicine and genetic diseases.

Verix boosts life science AI capabilities with start-up...

start-up.ai will be merged with Verix’s AI lab, and its co-founder and CEO Shaha...

FDA clears Genentech’s Columvi for adults with R/R DLBCL

Columvi is a CD20xCD3 T-cell engaging bispecific antibody designed to treat R/R ...